Background Phosphate binders are used to reduce positive phosphate balance and to lower
serum phosphate levels for people with chronic kidney disease (CKD) with the aim to …

BACKGROUND: Phosphate binders are widely used to control serum phosphorus levels in
patients with chronic kidney disease (CKD). We analyzed the effects of phosphate binders …

3 bromate ion C carbon Ca calcium Ca2+ calcium ion CaCO3 calcium carbonate CaSO4
calcium sulfate Cd cadmium Ce cerium Ce3+ trivalent cerium ion Ce4+ tetravalent cerium …

Uremic secondary hyperparathyroidism is a multifactorial and complex disease often
present in advanced stages of chronic kidney disease. The accumulation of phosphate, the …

Hyperphosphatemia is an inevitable consequence of end-stage chronic kidney disease and
is present in the majority of dialysis patients. Hyperphosphatemia is observationally and …

Hyperphosphataemia can be induced by three main conditions: a massive acute phosphate
load, a primary increase in renal phosphate reabsorption, and an impaired renal phosphate …

Abstract Background/Aims: Lanthanum carbonate (LC, FOSRENOL®) is an effective
phosphate binder for which tolerability and a safety profile have been reported in …

Background Chronic kidney disease–mineral and bone disorder (CKD–MBD) is a common
complication in CKD patients, particularly in those with end-stage renal disease that requires …

Despite 10 years of post‐marketing safety monitoring of the phosphate binder lanthanum
carbonate, concerns about aluminium‐like accumulation and toxicity persist. Here, we …

The strong association between nephrogenic systemic fibrosis (NSF) and exposure to
gadolinium-based contrast agents (GBCAs) has greatly affected the care of patients with …